Form 8-K - Current report:
SEC Accession No. 0001193125-24-063629
Filing Date
2024-03-08
Accepted
2024-03-08 16:04:31
Documents
14
Period of Report
2024-03-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d751961d8k.htm   iXBRL 8-K 32371
  Complete submission text file 0001193125-24-063629.txt   156951

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA harp-20240308.xsd EX-101.SCH 2855
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20240308_lab.xml EX-101.LAB 17977
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20240308_pre.xml EX-101.PRE 11261
15 EXTRACTED XBRL INSTANCE DOCUMENT d751961d8k_htm.xml XML 3648
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

EIN.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 24734268
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)